79 related articles for article (PubMed ID: 9216679)
1. Correlation of MDR1 expression and oncogenic activation in human epithelial ovarian carcinoma.
Schneider J; Centeno M; Jimenez E; Rodriguez-Escudero FJ; Romero H
Anticancer Res; 1997; 17(3C):2147-51. PubMed ID: 9216679
[TBL] [Abstract][Full Text] [Related]
2. nm23 expression in advanced and borderline ovarian carcinoma.
Schneider J; Romero H; Ruiz R; Centeno MM; Rodriguez-Escudero FJ
Anticancer Res; 1996; 16(3A):1197-202. PubMed ID: 8702236
[TBL] [Abstract][Full Text] [Related]
3. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
[TBL] [Abstract][Full Text] [Related]
4. [A study on C-erbB2, nm23 and p53 expressions in epithelial ovarian cancer and their clinical significance].
Liu L; Yang K
Zhonghua Fu Chan Ke Za Zhi; 1999 Feb; 34(2):101-4. PubMed ID: 11263193
[TBL] [Abstract][Full Text] [Related]
5. nm23-H1 expression defines a high-risk subpopulation of patients with early-stage epithelial ovarian carcinoma.
Schneider J; Pollán M; Jiménez E; Marenbach K; Martínez N; Volm M; Marx D; Meden H
Br J Cancer; 2000 May; 82(10):1662-70. PubMed ID: 10817501
[TBL] [Abstract][Full Text] [Related]
6. Correlation of MDR-1, nm23-H1 and H Sema E gene expression with histopathological findings and clinical outcome in ovarian and breast cancer patients.
Galani E; Sgouros J; Petropoulou C; Janinis J; Aravantinos G; Dionysiou-Asteriou D; Skarlos D; Gonos E
Anticancer Res; 2002; 22(4):2275-80. PubMed ID: 12174914
[TBL] [Abstract][Full Text] [Related]
7. [Immunohistochemical study of p53, c-erbB-2 and nm23 proteins in human gastric cancer].
Wei Z; Wu Y; Zhai Z
Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):378-81. PubMed ID: 10920922
[TBL] [Abstract][Full Text] [Related]
8. [Expressions and their clinical significance of bcl-2 and nm23 in epithelial ovarian carcinoma].
Cao LQ; Chen XM; Li X
Hunan Yi Ke Da Xue Xue Bao; 2000 Apr; 25(2):188-90. PubMed ID: 12212220
[TBL] [Abstract][Full Text] [Related]
9. Relationship of serum levels of tumor markers with tissue expression of gene products in ovarian carcinoma.
Sorak M; Arsenijević S; Lukić G; Arsenijević N; Ristić P; Pavlović S; Popović S; Baskić D
J BUON; 2007; 12(1):99-104. PubMed ID: 17436409
[TBL] [Abstract][Full Text] [Related]
10. Co-expression of the MDR1 gene and HSP27 in human ovarian cancer.
Schneider J; Jimenez E; Marenbach K; Marx D; Meden H
Anticancer Res; 1998; 18(4C):2967-71. PubMed ID: 9713493
[TBL] [Abstract][Full Text] [Related]
11. Influence of the c-erb B-2, nm23, bcl-2 and p53 protein markers on colorectal cancer.
Demirbaş S; Sücüllü I; Yildirim S; Celenk T
Turk J Gastroenterol; 2006 Mar; 17(1):13-9. PubMed ID: 16830272
[TBL] [Abstract][Full Text] [Related]
12. Correlation of P-glycoprotein overexpression and cellular prognostic factors in formalin-fixed, paraffin-embedded tumor samples from breast cancer patients.
Schneider J; Romero H
Anticancer Res; 1995; 15(3):1117-21. PubMed ID: 7645934
[TBL] [Abstract][Full Text] [Related]
13. Correlates of urokinase-type plasminogen activator in colorectal cancer: positive relationship with nm23 and c-erbB-2 protein expression.
Berney CR; Yang J; Fisher RJ; Russell PJ; Crowe PJ
Oncol Res; 1998; 10(1):47-54. PubMed ID: 9613457
[TBL] [Abstract][Full Text] [Related]
14. Association of mdr1 gene expression with other prognostic factors and clinical outcome in human breast cancer.
Punyammalee B; Manoromana S; Purisa W; Chariyalertsak S; Rerkamnuaychok B
J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S162-73. PubMed ID: 9347665
[TBL] [Abstract][Full Text] [Related]
15. Expression of antimetastatic gene nm23-H1 in epithelial ovarian cancer.
Qian M; Feng Y; Xu L; Zheng S; Zhou X
Chin Med J (Engl); 1997 Feb; 110(2):142-4. PubMed ID: 9594287
[TBL] [Abstract][Full Text] [Related]
16. [Significance of COX-2, p53, proliferating cell nuclear antigen and nm23 expressions in gastric cancer and its behavior].
Ji SQ; Hua YW; Zhuang J; Gao Y; Kong Y; Han SL; Shao YF
Ai Zheng; 2002 Jun; 21(6):619-24. PubMed ID: 12452062
[TBL] [Abstract][Full Text] [Related]
17. Expression of nm23-H1 gene product in sarcomatous cancer cells of renal cell carcinoma: correlation with tumor stage and expression of matrix metalloproteinase-2, matrix metalloproteinase-9, sialyl Lewis X, and c-erbB-2.
Ohba K; Miyata Y; Koga S; Kanda S; Kanetake H
Urology; 2005 May; 65(5):1029-34. PubMed ID: 15882758
[TBL] [Abstract][Full Text] [Related]
18. Expression of c-myc, erbB-2, p53 and nm23-H1 gene product in benign and malignant breast lesions: coexpression and correlation with clinicopathologic parameters.
Sirotkovic-Skerlev M; Krizanac S; Kapitanovic S; Husnjak K; Unusic J; Pavelic K
Exp Mol Pathol; 2005 Aug; 79(1):42-50. PubMed ID: 16005711
[TBL] [Abstract][Full Text] [Related]
19. Biological and clinical significance of concurrent p53 gene alterations, MDR1 gene expression, and S-phase fraction analyses in breast cancer patients treated with primary chemotherapy or radiotherapy.
Chevillard S; Lebeau J; Pouillart P; de Toma C; Beldjord C; Asselain B; Klijanienko J; Fourquet A; Magdelénat H; Vielh P
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2471-8. PubMed ID: 9815649
[TBL] [Abstract][Full Text] [Related]
20. Comparison of histological changes and changes in nm23 and c-MET expression between primary and metastatic sites in osteosarcoma: a clinicopathologic and immunohistochemical study.
Oda Y; Naka T; Takeshita M; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2000 Jun; 31(6):709-16. PubMed ID: 10872665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
